ClinicalTrials.gg
RecruitingNCT07630142Updated Nov 5, 2026

Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.

An interventional study of Percussion Therapy and Longitudinal stripping masage in Chronic Neck Pain, sponsored by Poznan University of Physical Education. Recruiting at 1 site in Poland. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Poznan University of Physical Education · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 5, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study evaluates whether a single session of percussion therapy can reduce muscle tension and increase blood flow in the transverse cervical artery in individuals with neck pain. The investigators will evaluate muscle stiffness using ultrasound elastography, and assess blood flow in the transverse cervical artery via Doppler imaging before and after treatment. The primary objective is to determine how this therapy affects neck muscle relaxation and vascular responses, specifically within the upper trapezius region.

02

Conditions studied

  • Chronic Neck Pain

Browse trials for

Keywords

  • neck pain
  • longitudinal stripping massage
  • percussion massage
  • trapezius
  • elastography
  • shear wave
  • Doppler ultrasound
  • cervical pain
03

In context

Neck Pain

1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.

This study's planned enrollment of 35 is below the median of 50 across 1,122 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Poznan University of Physical Education is the lead sponsor of 91 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 5, 2026. See what changed

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 18-60 years
  • Neck pain persisting for at least 3 months
  • Visual Analog Scale (VAS) score between 3 and 7
  • Neck Disability Index (NDI) between 20% and 48%

Exclusion criteria

Exclusion Criteria:

  • Pregnancy and postpartum period
  • History of cervical spine or shoulder surgery
  • Diagnosed fibromyalgia, radiculopathy, or myelopathy
  • Myofascial therapy within the last 3 months
  • Use of analgesic medication within 48 hours before assessment
  • Venous diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Percussion Therapy Arm

    Subjects receiving percussion therapy using a massage device. Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.

    Device: Percussion Therapy

  • Experimental
    Longitudinal Stripping Massage Arm

    Subjects receiving manual longitudinal stripping massage. Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.

    Other: Longitudinal stripping masage

Interventions

  • DevicePercussion Therapy

    Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.

  • OtherLongitudinal stripping masage

    Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.

06

What researchers measure

Primary outcomes

  1. Neck pain intensity on Visual Analog Scale (VAS)

    Neck pain intensity evaluated using a Visual Analog Scale slide scale (score range 0-10, where 0 = no pain and 10 = worst imaginable pain). The patient marks their pain level using the slider, and the result is recorded as a numerical score. Unit of Measure: points

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Secondary outcomes

  1. Neck pain-related disability on Neck Disability Index (NDI)

    Neck pain-related disability measured with the Neck Disability Index (score range 0-50 points, where higher scores indicate greater disability). Unit of Measure: points

    Time frame: Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)

  2. Shear-wave elastography of upper trapezius muscle: mean stiffness

    Ultrasound shear-wave elastography of the upper trapezius muscle at the midpoint (foramen magnum-acromion line) to evaluate the mean stiffness value. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed at the midpoint of the trapezius. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the average value is used; repeated if discrepancies. Same researcher throughout. Unit of Measure: kilopascals (kPa)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  3. Myotonometry of upper trapezius muscle: oscillation frequency

    Assessment of myofascial tissue tone (oscillation frequency) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: hertz (Hz)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  4. Myotonometry of upper trapezius muscle: dynamic stiffness

    Assessment of biomechanical properties (dynamic stiffness) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: newtons per meter (N/m)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  5. Myotonometry of upper trapezius muscle: decrement

    Assessment of viscoelastic properties (logarithmic decrement of oscillation, reflecting elasticity) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: dimensionless

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  6. Active cervical range of motion: flexion

    Active cervical range of motion (flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  7. Active cervical range of motion: extension

    Active cervical range of motion (extension) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  8. Active cervical range of motion: right lateral flexion

    Active cervical range of motion (right lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  9. Active cervical range of motion: left lateral flexion

    Active cervical range of motion (left lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  10. Active cervical range of motion: right rotation

    Active cervical range of motion (right rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  11. Active cervical range of motion: left rotation

    Active cervical range of motion (left rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Other outcomes

  1. Peak systolic velocity (Vs) of the transverse cervical artery.

    Doppler ultrasound of the transverse cervical artery to evaluate Vs. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. Unit of Measure: millimeters per second (mm/s)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  2. End-diastolic velocity (Vd) of the transverse cervical artery.

    Doppler ultrasound of the transverse cervical artery to evaluate Vd. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. • Unit of Measure: millimeters per second (mm/s)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

  3. Resistive index (RI) of the transverse cervical artery.

    Doppler ultrasound of the transverse cervical artery to evaluate RI. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. • Unit of Measure: dimensionless (lub ratio / score)

    Time frame: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient privacy and confidentiality in accordance with GDPR regulations and local bioethics committee guidelines.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jun 2028, 24 months after the start.

Of 768 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 24 months is above that.

Counting every sponsor, half of 777 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2026
First posted
Jun 5, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Jun 1, 2028
CompletionEst.
Jun 1, 2029
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedNeck Disability Index (NDI) between 3020% and 48%
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedNeck Disability Index (NDI) between 3020% and 48%
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07630142
Lead sponsor
Poznan University of Physical Education
Responsible party
Dawid Łochyński (PhD, Associate Professor, Poznan University of Physical Education) — Principal investigator
First posted
Jun 5, 2026
Start date
Jun 1, 2026
Primary completion
Jun 1, 2028 (estimated)
Completion
Jun 1, 2029 (estimated)
Last update
Nov 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion